Quarterly report · Q1
4078.TEDINET S100OUSM
Period2022-04-01 → 2022-06-30
Filed2022-08-05
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 31
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥21.4bn | 2022-04-01 → 2022-06-30 | Cons. | Net sales |
| Revenue | ¥80.1bn | 2021-04-01 → 2022-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥19.6bn | 2021-04-01 → 2021-06-30 | Cons. | Net sales |
| Operating income | ¥1.8bn | 2022-04-01 → 2022-06-30 | Cons. | Operating income |
| Operating income | ¥2.1bn | 2021-04-01 → 2021-06-30 | Cons. | Operating income |
| Ordinary income | ¥2.1bn | 2022-04-01 → 2022-06-30 | Cons. | Ordinary income |
| Ordinary income | ¥8.8bn | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥2.4bn | 2021-04-01 → 2021-06-30 | Cons. | Ordinary income |
| Profit before tax | ¥2.6bn | 2022-04-01 → 2022-06-30 | Cons. | Income before income taxes |
| Profit before tax | ¥2.4bn | 2021-04-01 → 2021-06-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥1.8bn | 2022-04-01 → 2022-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥6.7bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥1.6bn | 2021-04-01 → 2021-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥1.8bn | 2022-04-01 → 2022-06-30 | Cons. | Profit loss |
| Net income | ¥1.7bn | 2021-04-01 → 2021-06-30 | Cons. | Profit loss |
| Total assets | ¥127.2bn | at 2022-06-30 | Cons. | Assets |
| Total assets | ¥123.9bn | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥123.6bn | at 2021-06-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥43.2bn | at 2022-06-30 | Cons. | Liabilities |
| Total liabilities | ¥41.2bn | at 2022-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥84.0bn | at 2022-06-30 | Cons. | Net assets |
| Net assets / equity | ¥82.7bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥80.4bn | at 2021-06-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥12.5bn | at 2022-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥10.8bn | at 2022-03-31 | Cons. | Cash and deposits |
| EPS (basic) | ¥109.4 | 2022-04-01 → 2022-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥407.06 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥97.22 | 2021-04-01 → 2021-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 62.9% | at 2022-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 63.6% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 62.2% | at 2021-06-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 30
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-06-30 | −¥435m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-06-30 | −¥435m |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-06-30 | −¥558m |
| jpcrp040300-q1r_E00780-000Chemicalreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥19.8bn |
| jpcrp040300-q1r_E00780-000Chemicalreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥19.5bn |
| jpcrp040300-q1r_E00780-000Chemicalreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥360m |
| jpcrp040300-q1r_E00780-000Chemicalreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥2.3bn |
| jpcrp040300-q1r_E00780-000Medicine And Health Carereportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥2.0bn |
| jpcrp040300-q1r_E00780-000Medicine And Health Carereportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥1.9bn |
| jpcrp040300-q1r_E00780-000Medicine And Health Carereportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥74m |
| jpcrp040300-q1r_E00780-000Medicine And Health Carereportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥89m |
| —segment total | revenue | 2022-04-01 → 2022-06-30 | ¥21.8bn |
| —segment total | revenue external | 2022-04-01 → 2022-06-30 | ¥21.4bn |
| —segment total | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥435m |
| —segment total | segment profit | 2022-04-01 → 2022-06-30 | ¥2.4bn |
| Reconciling Itemsreconciling | revenue | 2021-04-01 → 2021-06-30 | −¥449m |
| Reconciling Itemsreconciling | revenue intersegment | 2021-04-01 → 2021-06-30 | −¥449m |
| Reconciling Itemsreconciling | segment profit | 2021-04-01 → 2021-06-30 | −¥521m |
| jpcrp040300-q1r_E00780-000Chemicalreportable segment | revenue | 2021-04-01 → 2021-06-30 | ¥18.1bn |
| jpcrp040300-q1r_E00780-000Chemicalreportable segment | revenue external | 2021-04-01 → 2021-06-30 | ¥17.7bn |
| jpcrp040300-q1r_E00780-000Chemicalreportable segment | revenue intersegment | 2021-04-01 → 2021-06-30 | ¥385m |
| jpcrp040300-q1r_E00780-000Chemicalreportable segment | segment profit | 2021-04-01 → 2021-06-30 | ¥2.6bn |
| jpcrp040300-q1r_E00780-000Medicine And Health Carereportable segment | revenue | 2021-04-01 → 2021-06-30 | ¥1.9bn |
| jpcrp040300-q1r_E00780-000Medicine And Health Carereportable segment | revenue external | 2021-04-01 → 2021-06-30 | ¥1.9bn |
| jpcrp040300-q1r_E00780-000Medicine And Health Carereportable segment | revenue intersegment | 2021-04-01 → 2021-06-30 | ¥63m |
| jpcrp040300-q1r_E00780-000Medicine And Health Carereportable segment | segment profit | 2021-04-01 → 2021-06-30 | ¥27m |
| —segment total | revenue | 2021-04-01 → 2021-06-30 | ¥20.0bn |
| —segment total | revenue external | 2021-04-01 → 2021-06-30 | ¥19.6bn |
| —segment total | revenue intersegment | 2021-04-01 → 2021-06-30 | ¥449m |
| —segment total | segment profit | 2021-04-01 → 2021-06-30 | ¥2.7bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 363
| Item | Context | Value | Unit |
|---|---|---|---|
| Independent auditors report consolidated (text) | FilingDateInstant | Text · Plus | |
| Audit firm1 consolidated | FilingDateInstant | Original text (Japanese)ひびき監査法人 | |
| Cpa1 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)安岐 浩一 | |
| Cpa2 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)宮本 靖士 | |
| Number of submission | FilingDateInstant | 1 | |
| Net sales (5-year summary) | Prior1YTDDuration | 19577000000 | JPY |
| Net sales (5-year summary) | CurrentYTDDuration | 21400000000 | JPY |
| Net sales (5-year summary) | Prior1YearDuration | 80135000000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YTDDuration | 2359000000 | JPY |
| Ordinary income loss (5-year summary) | CurrentYTDDuration | 2125000000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YearDuration | 8840000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YTDDuration | 1636000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | CurrentYTDDuration | 1769000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YearDuration | 6747000000 | JPY |
| Comprehensive income (5-year summary) | Prior1YTDDuration | 1344000000 | JPY |
| Comprehensive income (5-year summary) | CurrentYTDDuration | 1933000000 | JPY |
| Comprehensive income (5-year summary) | Prior1YearDuration | 5714000000 | JPY |
| Net assets (5-year summary) | Prior1QuarterInstant | 80419000000 | JPY |
| Net assets (5-year summary) | CurrentQuarterInstant | 84028000000 | JPY |
| Net assets (5-year summary) | Prior1YearInstant | 82708000000 | JPY |
| Total assets (5-year summary) | Prior1QuarterInstant | 123625000000 | JPY |
| Total assets (5-year summary) | CurrentQuarterInstant | 127230000000 | JPY |
| Total assets (5-year summary) | Prior1YearInstant | 123919000000 | JPY |
| Basic earnings loss per share (5-year summary) | Prior1YTDDuration | 97.22 | |
| Basic earnings loss per share (5-year summary) | CurrentYTDDuration | 109.40 | |
| Basic earnings loss per share (5-year summary) | Prior1YearDuration | 407.06 | |
| Diluted earnings per share (5-year summary) | Prior1YTDDuration | － | |
| Diluted earnings per share (5-year summary) | CurrentYTDDuration | － | |
| Diluted earnings per share (5-year summary) | Prior1YearDuration | － | |
| Equity to asset ratio (5-year summary) | Prior1QuarterInstant | 0.622 | |
| Equity to asset ratio (5-year summary) | CurrentQuarterInstant | 0.629 | |
| Equity to asset ratio (5-year summary) | Prior1YearInstant | 0.636 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 17000000 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 17000000 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 17000000 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 17000000 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithNoVotingRightsMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember | 827200 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 16115600 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 161156 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember | 57200 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant | 17000000 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant | 161156 | |
| Number of shares held in own name treasury shares etc | CurrentQuarterInstant_Row1Member | 827200 | |
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant_Row1Member | － | |
| Total number of shares held treasury shares etc | CurrentQuarterInstant_Row1Member | 827200 | |
| Shareholding ratio treasury shares etc | CurrentQuarterInstant_Row1Member | 0.0487 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |